GSK : ViiV Healthcare receives approval from China's National Medical Products Administration (NMPA) for Vocabria (cabotegravir) used in combination with Rekambys (rilpivirine), the first and only complete long-acting HIV-1 injectable treatment - Form 6-K -October 26, 2023 at 08:20 am EDT
A3337rgskplcedgar UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington,...